Windham Venture Partners

Founded in 2006, Windham is a New York City based venture capital firm focused on healthcare, with a particular emphasis on medical technology (devices and diagnostics) and digital health (the intersection of biology, genomics, and information technology).

Windham seeks to invest in and partner with companies that are commercializing game-changing technologies to serve unmet needs in order to improve the lives of large numbers of patients and yield robust returns for its investors.

For more information visit: www.windhamvp.com

Windham Venture Partners, established in 2006 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Biotechnology, Health Care, Medical, Medical Device, Financial Services, Venture Capital, Finance, Consumer, Pharmaceutical, Software. The organization boasts a portfolio of 58 investments, with an average round size of $35.5M and 10 successful exits. Their recent investments include Neotract, New Enterprise Associates, Johnson & Johnson Development Corporation, Quadrille Capital, Transactis. The highest investment round they participated in was $214.6B. Among their most notable exits are Neotract and New Enterprise Associates. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.